Literature DB >> 6119322

Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.

W H Hoffman, P Sahasrananan, S S Ferandos, C L Burek, N R Rose.   

Abstract

A thyrotoxic infant was delivered to a woman with a long-standing history of Hashimoto's thyroiditis, but with no evidence of Graves' disease. Long-acting thyroid stimulator (LATS) and LATS protector were absent, but thyroid-stimulating antibody was transiently present in the infant and markedly and persistently elevated in the mother. It is concluded that the maternal level of thyroid-stimulating immunoglobulins determines the presence and duration of transient neonatal thyrotoxicosis, and that thyroid-stimulating antibody is distinct from LATS and LATS protector.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6119322     DOI: 10.1210/jcem-54-2-354

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Thyroid-stimulating immunoglobulins and thyroid function tests in two siblings with neonatal thyrotoxicosis.

Authors:  J M Wit; B Rees-Smith; F M Creagh; H W Bruinse; D van der Heide; R Docter; L J Gerards
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

2.  Autoimmune thyroid disease and pregnancy.

Authors:  A M McGregor; R Hall; C Richards
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

3.  Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.

Authors:  M Zakarija; J M McKenzie; D S Munro
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

Review 4.  Neonatal thyroid disorders.

Authors:  A L Ogilvy-Stuart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.